Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioCeramic Therapeutics appoints new CEO

This article was originally published in Clinica

Executive Summary

Ian Brown has succeeded Daniel Green as CEO of BioCeramic Therapeutics (BCT), as the UK tissue regeneration products company enters its next stage of commercial growth. Mr Green, who has been at BCT since it was spun out of Imperial College, will remain as a board director. Mr Brown has held senior executive roles in both large multinationals and small- to medium-sized companies. His experience covers, among other things, M&A transactions and post-deal integration, fundraisings and IPOs. He joins London-based BCT as the firm is close to commercialising its first products, which include bioceramics for hard tissue treatment and flexible biomimetic scaffold for tissue engineering.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT045230

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel